Omnicell Net Profit Margin 2010-2025 | OMCL

Omnicell net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Omnicell Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $1.14B $0.02B 1.94%
2024-12-31 $1.11B $0.01B 1.17%
2024-09-30 $1.06B $-0.02B -1.60%
2024-06-30 $1.08B $-0.02B -1.85%
2024-03-31 $1.10B $-0.02B -1.90%
2023-12-31 $1.15B $-0.02B -1.74%
2023-09-30 $1.19B $-0.03B -2.86%
2023-06-30 $1.24B $-0.02B -1.86%
2023-03-31 $1.27B $-0.02B -1.34%
2022-12-31 $1.30B $0.01B 0.46%
2022-09-30 $1.31B $0.05B 3.67%
2022-06-30 $1.26B $0.06B 4.77%
2022-03-31 $1.20B $0.07B 5.92%
2021-12-31 $1.13B $0.08B 6.80%
2021-09-30 $1.07B $0.08B 7.38%
2021-06-30 $0.99B $0.06B 5.97%
2021-03-31 $0.92B $0.04B 3.83%
2020-12-31 $0.89B $0.03B 3.58%
2020-09-30 $0.89B $0.04B 4.26%
2020-06-30 $0.91B $0.05B 5.40%
2020-03-31 $0.92B $0.07B 7.47%
2019-12-31 $0.90B $0.06B 6.80%
2019-09-30 $0.86B $0.05B 6.27%
2019-06-30 $0.84B $0.05B 5.74%
2019-03-31 $0.81B $0.04B 4.83%
2018-12-31 $0.79B $0.04B 4.95%
2018-09-30 $0.77B $0.06B 7.12%
2018-06-30 $0.76B $0.05B 6.49%
2018-03-31 $0.75B $0.04B 5.89%
2017-12-31 $0.71B $0.03B 4.35%
2017-09-30 $0.69B $0.01B 1.30%
2017-06-30 $0.68B $0.00B 0.44%
2017-03-31 $0.67B $0.00B 0.00%
2016-12-31 $0.70B $0.01B 1.44%
2016-09-30 $0.65B $0.01B 1.38%
2016-06-30 $0.60B $0.02B 2.50%
2016-03-31 $0.54B $0.03B 4.64%
2015-12-31 $0.48B $0.03B 6.40%
2015-09-30 $0.48B $0.03B 6.72%
2015-06-30 $0.46B $0.03B 6.68%
2015-03-31 $0.46B $0.03B 6.58%
2014-12-31 $0.44B $0.03B 6.79%
2014-09-30 $0.43B $0.03B 6.57%
2014-06-30 $0.41B $0.03B 7.13%
2014-03-31 $0.40B $0.03B 6.82%
2013-12-31 $0.38B $0.02B 6.30%
2013-09-30 $0.37B $0.02B 6.30%
2013-06-30 $0.36B $0.02B 6.20%
2013-03-31 $0.34B $0.02B 5.06%
2012-12-31 $0.31B $0.02B 5.11%
2012-09-30 $0.29B $0.01B 4.90%
2012-06-30 $0.27B $0.01B 3.76%
2012-03-31 $0.25B $0.01B 4.76%
2011-12-31 $0.25B $0.01B 4.49%
2011-09-30 $0.24B $0.01B 3.35%
2011-06-30 $0.23B $0.01B 2.60%
2011-03-31 $0.23B $0.01B 2.22%
2010-12-31 $0.22B $0.01B 2.25%
2010-09-30 $0.22B $0.01B 2.27%
2010-06-30 $0.22B $0.01B 2.29%
2010-03-31 $0.22B $0.00B 1.85%
2009-12-31 $0.21B $0.00B 0.47%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.276B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.644B 58.07
Doximity (DOCS) United States $11.655B 53.96
Hims & Hers Health (HIMS) United States $11.295B 117.35
Tempus AI (TEM) United States $9.675B 0.00
IRhythm Technologies (IRTC) United States $4.275B 0.00
Inspire Medical Systems (INSP) United States $3.775B 58.99
Hinge Health (HNGE) United States $3.572B 0.00
Privia Health (PRVA) United States $2.516B 172.00
Enovis (ENOV) United States $1.765B 9.84
Phreesia (PHR) United States $1.591B 0.00
Clover Health Investments (CLOV) United States $1.517B 0.00
10x Genomics (TXG) United States $1.505B 0.00
Schrodinger (SDGR) United States $1.495B 0.00
Azenta (AZTA) United States $1.461B 67.89
Evolent Health (EVH) United States $1.335B 113.70
Claritev (CTEV) United States $0.717B 0.00
Fulgent Genetics (FLGT) United States $0.550B 0.00
Veradigm (MDRX) United States $0.536B 0.00
Standard BioTools (LAB) United States $0.463B 0.00
Butterfly Network (BFLY) United States $0.435B 0.00
Talkspace (TALK) United States $0.420B 125.50
TruBridge (TBRG) United States $0.321B 713.00
Outset Medical (OM) United States $0.320B 0.00
Nyxoah SA (NYXH) Belgium $0.270B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.213B 0.00
Zepp Health (ZEPP) Netherlands $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.136B 0.00
American Well (AMWL) United States $0.125B 0.00
EUDA Health Holdings (EUDA) Singapore $0.120B 0.00
Pulmonx (LUNG) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.083B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.080B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00